[1] Lv Zhuoren(吕卓人). Clinical application and research feature of angiotensin Ⅱ receptor antagonist(血管紧张素Ⅱ受体拮抗剂临床与研究热点)[J]. Cont Med Edu(继续医学教育), 2006, 20(1): 19-23.[2] Duncia J V, Chiu A T, Carini D J, et al. The discovery of potent nonpeptide angiotensin Ⅱ receptor antagonists: a new class of potent antihypertensives[J]. J Med Chem, 1990, 33(5): 1 312-1 329.[3] Wexler R R, Greenlee W J, Irvin J D, et al. Nonpeptide angiotensin II receptor antagonists: The next generation in antihypertensive therapy[J]. J Med Chem, 1996, 39(3): 625-656.[4] de Gasparo M, Catt K J , Inagami T, et al. International union of pharmacology. XXIII. The angiotensin Ⅱ receptors[J]. Pharmacol Rev, 2000, 52(3): 415-472.[5] Zoumpoulakis P, Politi A, Grdadolnik S G, et al. Structure elucidation and conformational study of V8 :A novel synthetic non peptide AT1 antagonist[J]. J Pharm Biomed Anal, 2006, 40:1 097-1 104.[6] Zoumpoulakis P, Zoga A, Roumelioti P, et al. Conformational and biological studies for a pair of novel synthetic AT(1) antagonists: stereoelectronic requirements for antihypertensive efficacy[J]. J Pharm Biomed Anal, 2003, 31(5): 833-844.[7] Ye Jin-xing(叶金星), Cheng Guo-bao(程国宝) , Hu Jie-han(胡皆汉). Study on computational chemistry of elemene and its derivatives(榄香烯及其衍生物的计算化学研究)[J]. Chinese J Magn Reson(波谱学杂志), 2000, 17(2): 115-120.[8] Su Yong-chao(苏永超), Zheng An-min(郑安民), Li Shen-hui(李申慧), et al. Quantum chemical calculation on 13C NMR shifts of small drug molecules(药物小分子化学位移的量子化学计算研究)[J]. Chinese J Magn Reson(波谱学杂志), 2006, 23(3): 293-301.[9] Frisch M J, Trucks G W, Schlegel H B, et al. Gaussian 03[CP] B.05 edit. Gaussian Inc Pittsburgh PA. 2003.[10] Mavromoustakos T, Kolocouris A, Zervou M, et al. An effort to understand the molecular basis of hypertension through the study of conformational analysis of losartan and sarmesin using a combination of nuclear magnetic resonance spectroscopy and theoretical calculations[J]. J Med Chem, 1999, 42(10): 1 714-1 722.[11] Zoumpoulakis P, Grdadolnik S G, Matsoukas J, et al. Structure elucidation and conformational properties of eprosartan a non peptide Angiotensin II AT(1) antagonist[J]. J Pharm Biomed Anal, 2002, 28(1): 125-135. |